The enhanced selectivity of IB may be related to the trapping of IB in the ER/lysosomes combined with the requirement for an ER-localized FLT3 mutant for effective tyrosine phosphorylation of STAT5 in AML (Figure 3). The gene discussed is FLT3; the disease is acute myeloid leukemia.